World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
78
Citations
22412
World Ranking
3790
National Ranking
1211

Richard A. Glennon publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Richard A. Glennon sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 644 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 253 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 424 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Richard A. Glennon D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard A. Glennon sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 776 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 647 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 78 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Richard A. Glennon is affiliated with Virginia Commonwealth University in the United States. Their research spans several interrelated fields, including neuroscience and psychology, with significant contributions to cellular and molecular neuroscience as well as clinical psychology. Their work also touches on organic chemistry, toxicology, and molecular biology.

The scientist's notable recent publications include:

  • 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review, 2024, published in ACS Pharmacology & Translational Science
  • Investigation of the Optical Isomers of Methcathinone, and Two Achiral Analogs, at Monoamine Transporters and in Intracranial Self-Stimulation Studies in Rats, 2020, published in ACS Chemical Neuroscience
  • Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca2+ channels as sensors, 2021, published in Toxicology and Applied Pharmacology
  • Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV, 2021, published in Neuropharmacology
  • A strategy to prioritize emerging drugs of abuse for analysis: Abuse liability testing using intracranial self-stimulation (ICSS) in rats and validation with α-pyrrolidinohexanophenone (α-PHP), 2021, published in Emerging Trends in Drugs Addictions and Health

Their research primarily explores topics such as:

  • Neurotransmitter Receptor Influence on Behavior
  • Psychedelics and Drug Studies
  • Chemical synthesis and alkaloids
  • Forensic Toxicology and Drug Analysis
  • Neuroscience and Neuropharmacology Research
  • Receptor Mechanisms and Signaling
  • Nicotinic Acetylcholine Receptors Study

Frequent coauthors in their work include:

  • Małgorzata Dukat
  • José M. Eltit
  • Vy Nguyen
  • Rachel A. Davies
  • Tyson R. Baird

Richard A. Glennon has published multiple papers in several prominent scientific venues. The most common publication outlets are:

  • ACS Pharmacology & Translational Science
  • ACS Chemical Neuroscience
  • Neuropharmacology
  • Toxicology and Applied Pharmacology
  • Emerging Trends in Drugs Addictions and Health

Best Publications

  • Predicting new molecular targets for known drugs

    Michael J. Keiser;Vincent Setola;John J. Irwin;Christian Laggner

  • Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

    Richard A. Glennon;Milt Titeler;J.D. McKenney

  • Central serotonin receptors as targets for drug research.

    Richard A. Glennon

  • Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

    M. Titeler;R. A. Lyon;R. A. Glennon

  • 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro

    Vincent Setola;Sandra J. Hufeisen;K. Jane Grande-Allen;Ivan Vesely

  • Do functional relationships exist between 5-HT1A and 5-HT2 receptors?

    Nissar A. Darmani;Billy R. Martin;U. Pandey;Richard A. Glennon

  • Sigma receptor ligands and the use thereof

    Richard A. Glennon

  • Serotonin receptors: Clinical implications

    Richard A. Glennon

  • Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors.

    Richard A. Glennon;Malgorzata Dukat;Brian Grella;Seoung-Soo Hong

  • NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

    Richard A. Glennon;Noreen A. Naiman;M.Edward Pierson;M. Titeler

  • Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.

    N M Appel;W M Mitchell;R K Garlick;R A Glennon

  • Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.

    Richard A. Glennon;Richard Young;John A. Rosecrans

  • Higher-End Serotonin Receptors: 5-HT5, 5-HT6, and 5-HT7

    Richard A. Glennon

  • Antinociceptive Responses to Nicotinic Acetylcholine Receptor Ligands after Systemic and Intrathecal Administration in Mice

    M. I. Damaj;M. Fei-Yin;M. Dukat;W. Glassco

  • In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates.

    Richard B. Rothman;Nga Vu;John S. Partilla;Bryan L. Roth

  • 2-Substituted Tryptamines: Agents with Selectivity for 5-HT6 Serotonin Receptors |

    Richard A. Glennon;Mase Lee;Jagadeesh B. Rangisetty;Malgorzata Dukat

  • Structural features important for sigma 1 receptor binding.

    Richard A. Glennon;Seth Y. Ablordeppey;Abd M. Ismaiel;Mahmoud B. El-Ashmawy

  • Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.

    Jeff L. Herndon;Abd Ismaiel;Stacy P. Ingher;M. Teitler

  • Do classical hallucinogens act as 5-HT2 agonists or antagonists?

    Glennon Ra

  • 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinugen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA)

    Michael Shannon;George Battaglia;Richard A. Glennon;Milt Titeler

Frequent Co-Authors

Bryan L. Roth
Bryan L. Roth University of North Carolina at Chapel Hill
Billy R. Martin
Billy R. Martin Virginia Commonwealth University
Michael H. Baumann
Michael H. Baumann National Institute on Drug Abuse
Lemont B. Kier
Lemont B. Kier Virginia Commonwealth University
Richard B. Rothman
Richard B. Rothman National Institute on Drug Abuse
John W. Daly
John W. Daly National Institutes of Health
David J. Nutt
David J. Nutt Imperial College London
Javier González-Maeso
Javier González-Maeso Virginia Commonwealth University
Michael A. Sutton
Michael A. Sutton University of Michigan–Ann Arbor
Linda P. Dwoskin
Linda P. Dwoskin University of Kentucky

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career opportunities, many of which align with specialized degrees and certifications. For those interested in combining chemistry with law and justice, online programs like the best online associates in criminal justice offer a solid foundation for roles in forensic science or regulatory compliance.

Another path involves the legal support field, where understanding scientific terminology is advantageous. Exploring the types of paralegals can help clarify how chemistry graduates might transition into specialized paralegal roles focused on patent law or environmental regulations.

Careers in the pharmaceutical industry are highly relevant for chemistry majors. To enter the commercial side, learning how to get into pharmaceutical sales can provide valuable insights on leveraging scientific knowledge to bridge the gap between product development and healthcare providers.

For those aiming to practice directly in healthcare, understanding how do you become a pharmacist is crucial. This pathway requires advanced education but offers rewarding opportunities to apply chemistry expertise in patient care and medication management.

Best Scientists Citing Richard A. Glennon

Trending Scientists

Recently Published Articles